Hengehold Capital Management’s Medtronic MDT Stock Holding History

Hengehold Capital Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.29M	Buy	42,035 +1,041	+3%	+$84K	0.26%	67
2026 Q1	$3.55M	Buy	40,994 +652	+2%	+$62.5K	0.31%	62
2025 Q4	$3.88M	Buy	40,342 +747	+2%	+$72.6K	0.33%	60
2025 Q3	$3.77M	Buy	39,595 +1,563	+4%	+$144K	0.32%	61
2025 Q2	$3.32M	Buy	38,032 +161	+0.4%	+$13.7K	0.3%	63
2025 Q1	$3.4M	Buy	37,871 +1,402	+4%	+$125K	0.32%	59
2024 Q4	$2.91M	Buy	36,469 +468	+1%	+$40.5K	0.27%	63
2024 Q3	$3.24M	Buy	36,001 +2,714	+8%	+$228K	0.31%	63
2024 Q2	$2.62M	Buy	33,287 +483	+1%	+$39.6K	0.27%	65
2024 Q1	$2.86M	Buy	32,804 +10,074	+44%	+$860K	0.3%	63
2023 Q4	$1.87M	Sell	22,730 -436	-2%	-$33.2K	0.22%	63
2023 Q3	$1.82M	Buy	23,166 +832	+4%	+$69.6K	0.24%	62
2023 Q2	$1.97M	Sell	22,334 -36	-0.2%	-$3.1K	0.26%	60
2023 Q1	$1.8M	Buy	22,370 +1,113	+5%	+$90.7K	0.25%	61
2022 Q4	$1.65M	Sell	21,257 -9,811	-32%	-$795K	0.23%	62
2022 Q3	$2.51M	Sell	31,068 -90	-0.3%	-$8.09K	0.39%	48
2022 Q2	$2.8M	Buy	31,158 +1,920	+7%	+$195K	0.4%	43
2022 Q1	$3.24M	Buy	29,238 +386	+1%	+$40.8K	0.44%	38
2021 Q4	$2.98M	Buy	28,852 +693	+2%	+$80.2K	0.37%	40
2021 Q3	$3.53M	Buy	28,159 +286	+1%	+$37K	0.46%	34
2021 Q2	$3.46M	Sell	27,873 -30	-0.1%	-$3.77K	0.45%	35
2021 Q1	$3.3M	Buy	27,903 +61	+0.2%	+$7.15K	0.46%	37
2020 Q4	$3.26M	Buy	27,842 +30	+0.1%	+$3.3K	0.49%	26
2020 Q3	$2.89M	Sell	27,812 -192	-0.7%	-$19.3K	0.47%	27
2020 Q2	$2.57M	Sell	28,004 -578	-2%	-$55.4K	0.46%	31
2020 Q1	$2.58M	Sell	28,582 -279	-1%	-$29.7K	0.55%	25
2019 Q4	$3.27M	Buy	28,861 +214	+0.7%	+$23.5K	0.56%	24
2019 Q3	$3.11M	Sell	28,647 -187	-0.6%	-$19.5K	0.57%	25
2019 Q2	$2.81M	Buy	28,834 +404	+1%	+$36.9K	0.54%	33
2019 Q1	$2.59M	Buy	28,430 +813	+3%	+$72.8K	0.61%	33
2018 Q4	$2.51M	Buy	27,617 +1,759	+7%	+$164K	0.81%	28
2018 Q3	$2.54M	Buy	25,858 +752	+3%	+$69.5K	0.64%	30
2018 Q2	$2.15M	Buy	+25,106	New	+$2.1M	0.56%	36

Other funds holding MDT

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

GAM

Guinness Asset Management London, United Kingdom $5.91B AUM 21.44% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

SRIM

Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Hengehold Capital Management's MDT Position: Q2 2026 in Review

Hengehold Capital Management increased its Medtronic (MDT) stake by 2.5% in Q2 2026, buying an estimated $84K and bringing the position to 42,035 shares worth $3.29M. The position accounts for 0.26% of the portfolio, ranked #67.

Hengehold Capital Management first reported a position in MDT in Q2 2018 and has held it in 33 quarters since. The position peaked at $3.88M in Q4 2025. 961 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

Hengehold Capital Management held 42,035 shares of Medtronic worth $3.29M as of Q2 2026.
Hengehold Capital Management bought 1,041 Medtronic shares in Q2 2026, an estimated $84K.
Medtronic made up 0.26% of Hengehold Capital Management's portfolio in Q2 2026, its #67 holding.
Hengehold Capital Management first reported a position in Medtronic in Q2 2018 and has held it in 33 quarters since.
Hengehold Capital Management's Medtronic position peaked at $3.88M in Q4 2025.
961 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Hengehold Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.